𝛼SK or Search

ENTITY

Silexion Therapeutics (SLXN US)

3

Analysis

Health Care • United States

Silexion Therapeutics Corp is a clinical-stage, oncology-focused biotechnology company developing proprietary RNA interference (RNAi) therapies for KRAS-driven cancers. The company is offering shares and warrants in a best-efforts offering to advance its pre-clinical and clinical studies and for general corporate purposes.

more

Refresh

Exchange Announcement • 30 Sep 2026 20:52

Current Report (Form 8-K | Period ending 2026-09-30)

Exchange Announcement • 29 Sep 2026 22:35

424B3 | Prospectus

Exchange Announcement • 29 Sep 2026 22:31

Current Report (Form 8-K | Period ending 2026-09-28)

Exchange Announcement • 28 Sep 2026 20:46

Current Report (Form 8-K | Period ending 2026-09-28)

Exchange Announcement • 22 Aug 2026 04:21

Current Report (Form 8-K | Period ending 2026-08-21)

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4

x